Comparison of analgesic effect of Paracetamol with combination of Paracetamol and Propofol in the relief of acute migraine headache

Survey of the analgesic effect of venous Paracetamol in comparison with the combination of venous Paracetamol and Propofol in the relief of acute migraine headache

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20180628040274N1

Enrollment

Registered

2018-08-24

Start date

2018-08-21

Completion date

Unknown

Last updated

2018-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute migraine headache. Migraine

Interventions

Intervention 1: Intervention group1: Paracetamol recipients - After giving explanations and obtaining the written consent of individuals to participate in the project, this group will receive 1000 mg

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Failure to receive narcotic drugs or other Triptans, such as vasoconstrictor, such as Dihydroergotamine, within 24 hours before referral to the emergency department Patients treated with systemic Corticosteroids Patients with Diabetes Mellitus history, active gastrointestinal ulcers, myocardial infarction in the last week Family history of hypocalmic paralysis (for Dexamethasone)

Exclusion criteria

Exclusion criteria: Those who have kidney failure

Design outcomes

Primary

Measure	Time frame
Pain. Timepoint: Pain score is recorded based on the VAS scale before treatment and 5, 10, 20, 30, and 45 minutes after treatment. Method of measurement: By VAS or Visual Analogue Scale.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFarahnaz Ahmadi

Zahedan University of Medical Sciences

farahnaz.ahmadi@zaums.ac.ir+98 54 3329 5744

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026